11Feb/14

Children's Medical Center to Host 23 rd Annual 'Be The Match' Donor Registry … – Business Wire (press release)

Children’s Medical Center to Host 23 rd Annual ‘Be The Match’ Donor Registry
Business Wire (press release)
Another development has been the use of blood and marrow stem cell transplant to treat and even cure children with severe sickle cell disease, one of the most common serious genetic disorders in the world. Sickle cell disease is most commonly found 

and more »

11Feb/14

Resilience in parents of children undergoing stem cell transplant – Medical Xpress

Resilience in parents of children undergoing stem cell transplant
Medical Xpress
However, a study recently published in the journal Biology of Blood and Marrow Transplantation shows that in the case of a child’s stem cell transplant, parents feel increased distress at the time of the procedure, but eventually recover to normal
Children’s Medical Center to Host 23rd Annual ‘Be The Match’ Donor Registry The Herald | HeraldOnline.com (press release)

all 4 news articles »

11Feb/14

Study: Resilience in parents of children undergoing stem cell transplant – Science Codex

Study: Resilience in parents of children undergoing stem cell transplant
Science Codex
A child’s illness can challenge a parent’s wellbeing. However, a study recently published in the journal Biology of Blood and Marrow Transplantation shows that in the case of a child’s stem cell transplant, parents feel increased distress at the time
Children’s Medical Center to Host 23rd Annual ‘Be The Match’ Donor Registry The Herald | HeraldOnline.com (press release)

all 5 news articles »

11Feb/14

Study: Resilience in Parents of Children Undergoing Stem Cell Transplant – Newswise (press release)

Study: Resilience in Parents of Children Undergoing Stem Cell Transplant
Newswise (press release)
Newswise — A child’s illness can challenge a parent’s wellbeing. However, a study recently published in the journal Biology of Blood and Marrow Transplantation shows that in the case of a child’s stem cell transplant, parents feel increased distress

11Feb/14

Gilead seeks approval for Hepatitis C drug that's innovative — and expensive – San Francisco Chronicle (blog)

Gilead seeks approval for Hepatitis C drug that’s innovative — and expensive
San Francisco Chronicle (blog)
Gilead is also taking heat internationally for its plans to bring Sovaldi to India and other developing countries at a fraction of the U.S. price, about $2,500 for six months of treatment, according to an interview with an Indian pharmaceutical